Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

L.A. McKeown

December 17, 2021

News Conference News AHA 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

Todd Neale

November 15, 2021

News Conference News AHA 2021

Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data

Yael L. Maxwell

November 15, 2021

News Features

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

Shelley Wood

October 08, 2021

News Daily News

Lidocaine Less Likely Than Fentanyl to Blunt P2Y12 Inhibitors in the Cath Lab

L.A. McKeown

September 07, 2021

News Daily News

ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority

Yael L. Maxwell

July 01, 2021

New CV Surgery Guidelines Shift Focus to ‘Blood Management’

News Daily News

CV Surgery Societies Urge Shift to ‘Blood Management’

Yael L. Maxwell

June 30, 2021

News Daily News

OMT Boosts Survival in Revascularized Patients at 10 Years

Michael O'Riordan

June 29, 2021

Crushing Prasugrel Tabs Ups Platelet Inhibition Following Primary PCI

News Daily News

Crushed Prasugrel in the Ambulance Ups Platelet Inhibition in Primary PCI

Yael L. Maxwell

June 22, 2021

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Daily News

Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All

L.A. McKeown

April 05, 2021

News Daily News

Antithrombotic Therapy for COVID-19: Challenges and Lessons for the Future

L.A. McKeown

March 17, 2021

News Daily News

Potent Antiplatelets Pre-CABG for ACS? Meta-analysis Stirs Debate

L.A. McKeown

February 26, 2021

News Daily News

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Michael O'Riordan

February 04, 2021

Advertisement

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

Lidocaine Less Likely Than Fentanyl to Blunt P2Y12 Inhibitors in the Cath Lab

ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority

CV Surgery Societies Urge Shift to ‘Blood Management’

OMT Boosts Survival in Revascularized Patients at 10 Years

Crushed Prasugrel in the Ambulance Ups Platelet Inhibition in Primary PCI

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All

Antithrombotic Therapy for COVID-19: Challenges and Lessons for the Future

Potent Antiplatelets Pre-CABG for ACS? Meta-analysis Stirs Debate

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content